BioMelbourne Network Members Invited to Meet with International Medtronic Diabetes Representative
US based Medtronic representative, Dr Huzefa Neemuchwala, will be in Melbourne this month. BioMelbourne Network member organisations are invited to meet with Dr Neemuchwala. Interested organisations, please contact Dr Krystal Evans on 9667 6161 Dr Huzefa Neemuchwala, PhD MBA,…
FULLY BOOKED – Free Seminar with Dr Gerald Chan – The Role of Universities in the Innovation Ecosystem
THIS SEMINAR IS FULLY BOOKED The BioMelbourne Network and Biomedical Research Victoria present international guest speaker, Dr Gerald Chan, CEO, Morningside, USA Free Seminar: The Role of Universities in the Innovation Ecosystem With Australia’s changing economy, the role of universities…
Minister announces details of Biomedical Translation Fund
Innovation Minister Greg Hunt and Health Minister Sussan Ley have announced the details of the $500 million Biomedical Translation Fund (BTF), including the guidelines. In a joint statement with Health Minister Sussan Ley, Mr Hunt said the Government’s…
Big step towards cure for lifelong viral infections
New research has taken us a step closer to finding a cure for human immunodeficiency virus (HIV), as well as other infections including the glandular fever virus, which is associated with the development of lymphoma. Some infections, such…
Breakthrough lung cancer drug discovery by Melbourne researchers
26th July, 2016 A BREAKTHROUGH discovery has opened up a potential new drug to stop lung cancer and emphysema as well as detecting the killer diseases much sooner. Researchers from Melbourne’s Hudson Institute of Medical Science have identified…
Monash part of world-first clinical trial for lymphoma patients
26th July, 2016 A novel therapy for aggressive lymphoma is being tested in a world-first clinical trial at the Monash Health Translation Precinct (MHTP).In early 2015, researchers at Monash University and Peter MacCallum Cancer Centre showed the novel…
Burnet Institute and ARTES join forces to develop novel hepatitis C vaccine
27th July, 2016 The Melbourne based Burnet Institute and ARTES Biotechnology announce they have joined forces to develop a novel, effective vaccine to prevent transmission of hepatitis C virus (HCV). An HCV vaccine is urgently needed to prevent…
Opthea Reports Positive Data from wet AMD Clinical Trial
26th July, 2016 Melbourne, Australia, July 26 2016 – Opthea Limited (ASX:OPT) • Phase 1 dose escalation study met primary objective demonstrating OPT-302 safety and tolerability as monotherapy and in combination with standard of care Lucentis® • Changes…
Stem cells healing broken hearts; Making cancer treatment less aggressive, more effective
The National Stem Cell Foundation of Australia (based in Victoria) supports stem cell science and educates the community about the potential and dangers of stem cell therapies.The winners of the 2016 Metcalf Prizes for Stem Cell Research were…
Launch of Medical Technology and Pharmaceuticals Growth Centre
26th July, 2016 MTP Connect chief executive officer Sue MacLeman says her Federal Government funded initiative aim is “to drive competitiveness and productivity of the sector”. Ms MacLeman told Biotech Daily that the launch of a 10-year plan…
Animation library to increase science literacy in Victoria
26th July, 2016 The Walter and Eliza Hall Institute of Medical Research will embark on an exciting new project to create a free online database of more than 100 scientifically accurate 3D biomedical animations.Addressing a strong demand within…
Genomics Innovation Hub to enable personalised cancer treatment
21st July 2016 The University of Melbourne and the Australian Genomics Research Facility (AGRF) have launched the Genomics Innovation Hub — a collaborative initiative that will help pave the way for personalised cancer treatments based on patients’ genetic…
